HLTH: How AMGEN is Transforming Patient Engagement and Trial Diversity with Marisa Cruz

About Marisa Cruz:

Dr. Marisa Cruz is the Vice President of Global Digital Medicine at AMGEN, a renowned global biotechnology company. An endocrinologist and internist, she continues to practice medicine at UCSF, bringing a clinical perspective to her work in digital health. Dr. Cruz oversees AMGEN’s digital health strategy, focusing on harnessing data and technology to improve patient outcomes and bridge healthcare accessibility gaps.

Things You’ll Learn:

• AMGEN is driving innovation in digital health with initiatives like the LATTICE Consortium, aiming to reduce cardiovascular incidents by 50%.
• AI and machine learning are playing a crucial role in improving clinical trial diversity and accessibility.
• Emerging digital health trends, including implementation science and patient-centered care, are reshaping the future of healthcare.
• AMGEN’s patient engagement platform, PARC, empowers patients to actively participate in their own healthcare journey.

Resources:

• Connect with and follow Marisa Cruz on LinkedIn.
• Follow Amgen on LinkedIn and visit their website.
• Explore Amgen PARC website
• Discover the LATTICE Consortium website.